Resumen de acción 1066
Shandong Weigao Group Medical Polymer Company Limited se dedica a la investigación y desarrollo, producción, venta al por mayor y venta de productos sanitarios en la República Popular China.
| Puntuación del copo de nieve | |
|---|---|
| Valoración | 6/6 |
| Crecimiento futuro | 1/6 |
| Resultados anteriores | 2/6 |
| Salud financiera | 6/6 |
| Dividendos | 4/6 |
Recompensas
Análisis de riesgos
Competidores de Shandong Weigao Group Medical Polymer Company Limited
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | HK$3.94 |
| Máximo en 52 semanas | HK$10.62 |
| Mínimo de 52 semanas | HK$3.60 |
| Beta | 0.38 |
| 11 mes Cambio | 1.29% |
| Variación en 3 meses | -22.75% |
| Cambio de 1 año | -62.55% |
| 3Variación en 3 años | -71.70% |
| Variación en 5 años | -45.28% |
| Variación desde la OPV | 2,184.06% |
Noticias y actualizaciones recientes
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 27% Share Price Plunge Could Signal Some Risk
Jun 25
Here's What To Make Of Shandong Weigao Group Medical Polymer's (HKG:1066) Decelerating Rates Of Return
Jun 23Shandong Weigao Group Medical Polymer's (HKG:1066) Shareholders Will Receive A Bigger Dividend Than Last Year
May 31We Think Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) CEO Compensation Package Needs To Be Put Under A Microscope
May 22Recent updates
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 27% Share Price Plunge Could Signal Some Risk
Jun 25Here's What To Make Of Shandong Weigao Group Medical Polymer's (HKG:1066) Decelerating Rates Of Return
Jun 23Shandong Weigao Group Medical Polymer's (HKG:1066) Shareholders Will Receive A Bigger Dividend Than Last Year
May 31We Think Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) CEO Compensation Package Needs To Be Put Under A Microscope
May 22Earnings Not Telling The Story For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Apr 23Analysts Have Lowered Expectations For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) After Its Latest Results
Mar 28Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Shares May Have Run Too Fast Too Soon
Jan 09Returns On Capital Are Showing Encouraging Signs At Shandong Weigao Group Medical Polymer (HKG:1066)
Dec 22Are Investors Undervaluing Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) By 44%?
Nov 10Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?
Oct 05Return Trends At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Appealing
Aug 01Is Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Trading At A 28% Discount?
Jul 19Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth
Jun 22Is Shandong Weigao Group Medical Polymer (HKG:1066) Using Too Much Debt?
Jun 09The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing
Apr 27Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth
Mar 17A Look At The Intrinsic Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Feb 27Returns On Capital At Shandong Weigao Group Medical Polymer (HKG:1066) Have Hit The Brakes
Jan 18Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?
Dec 12Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 21% Below Their Intrinsic Value Estimate
Nov 29Here's Why We Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today
Nov 14Shandong Weigao Group Medical Polymer (HKG:1066) Is Paying Out A Larger Dividend Than Last Year
Oct 03The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing
Sep 21Shandong Weigao Group Medical Polymer (HKG:1066) Could Easily Take On More Debt
Sep 05Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Intrinsic Value Is Potentially 27% Above Its Share Price
Aug 23Here's Why Shandong Weigao Group Medical Polymer (HKG:1066) Has Caught The Eye Of Investors
Aug 08There's Been No Shortage Of Growth Recently For Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital
Jun 22Shandong Weigao Group Medical Polymer (HKG:1066) Will Pay A Smaller Dividend Than Last Year
Jun 08An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 27% Undervalued
May 16Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?
May 03Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital Are Heading Higher
Mar 17Is There An Opportunity With Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 42% Undervaluation?
Jan 28Does Shandong Weigao Group Medical Polymer (HKG:1066) Deserve A Spot On Your Watchlist?
Jan 13Returns Are Gaining Momentum At Shandong Weigao Group Medical Polymer (HKG:1066)
Dec 17Shandong Weigao Group Medical Polymer (HKG:1066) Seems To Use Debt Rather Sparingly
Dec 05An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 32% Undervalued
Oct 18Do Shandong Weigao Group Medical Polymer's (HKG:1066) Earnings Warrant Your Attention?
Oct 06Shandong Weigao Group Medical Polymer (HKG:1066) Shareholders Will Want The ROCE Trajectory To Continue
Sep 10Shandong Weigao Group Medical Polymer (HKG:1066) Has A Rock Solid Balance Sheet
Aug 29Calculating The Fair Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Jul 09Here's Why I Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today
Jun 26Investors Met With Slowing Returns on Capital At Shandong Weigao Group Medical Polymer (HKG:1066)
Jun 02These 4 Measures Indicate That Shandong Weigao Group Medical Polymer (HKG:1066) Is Using Debt Reasonably Well
Apr 24Rentabilidad de los accionistas
| 1066 | HK Medical Equipment | Mercado HK | |
|---|---|---|---|
| 7D | -2.7% | -2.5% | -1.9% |
| 1Y | -62.5% | -52.8% | -6.7% |
Rentabilidad vs. Industria: Los resultados de 1066 fueron inferiores a los de la industria Hong Kong Medical Equipment, que obtuvo un rendimiento del -43.4% el año pasado.
Rentabilidad vs. Mercado: 1066 obtuvo unos resultados inferiores a los del mercado Hong Kong, que fueron del -1.8% el año pasado.
Volatilidad de los precios
| 1066 volatility | |
|---|---|
| 1066 Average Weekly Movement | 5.4% |
| Medical Equipment Industry Average Movement | 6.9% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in HK Market | 14.1% |
| 10% least volatile stocks in HK Market | 3.6% |
Precio estable de las acciones: El precio de las acciones de 1066 ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de 1066 (5%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2000 | 12,519 | Rinan Cong | www.weigaogroup.com |
Shandong Weigao Group Medical Polymer Company Limited se dedica a la investigación y el desarrollo, la producción, la venta al por mayor y la venta de dispositivos médicos en la República Popular China. Opera a través de los segmentos de productos de dispositivos médicos, productos ortopédicos, productos intervencionistas, productos de envasado farmacéutico, productos para el tratamiento de la sangre y otros. La empresa ofrece consumibles y materiales médicos de un solo uso, incluidos equipos de infusión, jeringuillas, bolsas de sangre y segregadores de componentes sanguíneos consumibles, productos para la toma de muestras de sangre, jeringuillas precargadas para medicamentos preenvasados y agujas médicas que incluyen principalmente agujas intravenosas, agujas para jeringuillas, agujas para catéteres intravenosos, agujas para la toma de muestras de sangre y agujas irregulares; materiales e instrumentos ortopédicos, incluidos productos traumatológicos de placas y tornillos de acero, implantes espinales y articulaciones artificiales; y consumibles y equipos de purificación sanguínea, incluidas agujas de punción, circuitos sanguíneos extracorpóreos para conjuntos de purificación sanguínea, dializadores y consumibles relacionados.
Resumen de fundamentos de Shandong Weigao Group Medical Polymer Company Limited
| Estadísticas fundamentales de 1066 | |
|---|---|
| Capitalización bursátil | HK$18.01b |
| Beneficios(TTM) | HK$2.15b |
| Ingresos (TTM) | HK$14.24b |
8.4x
Ratio precio-beneficio (PE)1.3x
Ratio precio-ventas (PS)¿Está 1066 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 1066 | |
|---|---|
| Ingresos | CN¥13.23b |
| Coste de los ingresos | CN¥6.62b |
| Beneficio bruto | CN¥6.61b |
| Otros gastos | CN¥4.61b |
| Beneficios | CN¥2.00b |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0.44 |
| Margen bruto | 49.97% |
| Margen de beneficio neto | 15.13% |
| Ratio deuda/patrimonio | 16.8% |
¿Cómo se ha desempeñado 1066 a largo plazo?
Ver rendimiento histórico y comparativa